Top

Published in:

01-02-2022 | CO2 Laser | Review Article

A systematic review of randomised controlled trials investigating laser assisted drug delivery for the treatment of keloid and hypertrophic scars

Authors: Kelvin Truong, Ines Prasidha, Tevi Wain

Published in: Lasers in Medical Science | Issue 1/2022

Abstract

The objective of this article is to study the clinical efficacy and adverse events of laser-assisted drug delivery in the treatment of hypertrophic and keloid scars. We searched the following databases up to 22 October 2020: the Cochrane Skin Group Specialised Register, the Cochrane Central Register of Controlled Trials (Clinical Trials) in The Cochrane Library, MEDLINE, EMBASE, and reference lists of articles for randomised clinical trials (RCTs) of laser-assisted drug delivery for the treatment of hypertrophic and keloid scars. We also searched online trials registries for ongoing trials and contacted trial authors where appropriate. Our outcomes of interest were objective clinical evaluation of scars, participant satisfaction, and adverse effects of the treatments. Two authors independently extracted data and assessed trial quality using Cochrane Risk of Bias 2. Two authors independently abstracted data. We included 10 RCTs involving a total of 329 participants: six trials utilised parallel-arm RCTs whilst four employed split-scar design. Three trials had high risk of bias with the remaining seven rated as having some concerns. The interventions and outcomes were too varied to be combined statistically. High-quality randomised controlled trials assessing laser-assisted delivery for drugs in the context of hypertrophic and/or keloid scarring are needed. Studies with a larger number of participants, with longer follow-up times, and standardised evaluation of outcome and adverse effects are warranted.

Available only for authorised users

Bouzari N, Davis SC, Nouri K (2007) Laser treatment of keloids and hypertrophic scars. Int J Dermatol 46(1):80–88CrossRef

Berman B, Maderal A, Raphael B (2017) Keloids and hypertrophic scars: pathophysiology, classification, and treatment. Dermatol Surg 43(Suppl 1):S3–s18CrossRef

Shih B, Bayat A (2010) Genetics of keloid scarring. Arch Dermatol Res 302(5):319–339CrossRef

Sadiq, A., N.P. Khumalo, and A. Bayat, Genetics of Keloid Scarring, in Textbook on Scar Management: State of the Art Management and Emerging Technologies, L. Téot, et al., Editors. 2020, Springer International Publishing: Cham. p. 61-76.

Huang, C., et al., The Epidemiology of Keloids, in Textbook on Scar Management: State of the Art Management and Emerging Technologies, L. Téot, et al., Editors. 2020, Springer International Publishing: Cham. p. 29-35.

Kouwenberg CAE et al (2015) Emotional quality of life is severely affected by keloid disease: pain and itch are the main determinants of burden. Plastic and Reconstructive Surgery 136(4S):150–151CrossRef

Olaitan PB (2009) Keloids: assessment of effects and psychosocial-impacts on subjects in a black African population. Indian J Dermatol Venereol Leprol 75(4):368–372CrossRef

Betarbet U, Blalock TW (2020) Keloids: A review of etiology, prevention, and treatment. Journal of Clinical and Aesthetic Dermatology 13(2):33–43

Mustoe TA et al (2002) International clinical recommendations on scar management. Plast Reconstr Surg 110(2):560–571CrossRef

10.

Robles DT, Berg D (2007) Abnormal wound healing: keloids. Clin Dermatol 25(1):26–32CrossRef

11.

Limmer, E.E. and D.A. Glass, 2nd, A review of current keloid management: mainstay monotherapies and emerging approaches. Dermatol Ther (Heidelb), 2020. 10(5): p. 931-948.

12.

Braun SA et al (2016) Laser-assisted drug delivery: mode of action and use in daily clinical practice. J Dtsch Dermatol Ges 14(5):480–488PubMed

13.

Ali FR, Al-Niaimi F (2018) Treatment of nonmelanoma skin cancers using laser-assisted drug delivery. Dermatologic Surgery 44(2):310CrossRef

14.

Zaleski-Larsen LA, Fabi SG (2016) Laser-assisted drug delivery. Dermatol Surg 42(8):919–931CrossRef

15.

Manstein D et al (2004) Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 34(5):426–438CrossRef

16.

Park JH, Chun JY, Lee JH (2017) Laser-assisted topical corticosteroid delivery for the treatment of keloids. Lasers Med Sci 32(3):601–608CrossRef

17.

Cavalié M et al (2015) Treatment of keloids with laser-assisted topical steroid delivery: a retrospective study of 23 cases. Dermatol Ther 28(2):74–78CrossRef

18.

Sahib NH et al (2020) The role of fractional co2 laser in treatment of keloid and hypertrophic scar used alone and in combination with intralesional steroids. Indian Journal of Forensic Medicine and Toxicology 14(3):1545–1550

19.

Sabry, H.H., E.A. Ibrahim, and A.M. Hamed, Assessment of laser-assisted delivery vs intralesional injection of botulinum toxin A in treatment of hypertrophic scars and keloids. Dermatologic Therapy, 2020. n/a(n/a): p. e13980.

20.

Rahman, S.H.A., M.S. Mohamed, and A.M. Hamed, Efficacy and safety of Nd:YAG laser alone compared with combined Nd:YAG laser with intralesional steroid or botulinum toxin A in the treatment of hypertrophic scars. Lasers in Medical Science, 2020.

21.

Khattab FM et al (2020) Combination of pulsed dye laser and verapamil in comparison with verapamil alone in the treatment of keloid. Journal of Dermatological Treatment 31(2):186–190CrossRef

22.

Sabry HH et al (2019) The efficacy of combining fractional carbon dioxide laser with verapamil hydrochloride or 5-fluorouracil in the treatment of hypertrophic scars and keloids: A clinical and immunohistochemical study. Dermatologic Surgery 45(4):536–546CrossRef

23.

Woo Dk TGHMHRHJ-RDHI (2018) Prospective controlled trial for the treatment of acne keloidalis nuchae with a long-pulsed neodymium-doped yttrium-aluminum-garnet laser. Journal of cutaneous medicine and surgery 22(2):236CrossRef

24.

Alsharnoubi J, Mohamed O (2018) Photobiomodulation effect on children’s scars. Lasers in Medical Science 33(3):497–501CrossRef

25.

Chen XE et al (2017) Combined effects of long-pulsed neodymium-yttrium-aluminum-garnet laser, diprospan and 5-fluorouracil in the treatment of keloid scars. Experimental and Therapeutic Medicine 13(6):3607–3612CrossRef

26.

Asilian A, Darougheh A, Shariati F (2006) New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatologic Surgery 32(7):907–915PubMed

27.

Alster T (2003) Laser scar revision: Comparison study of 585-nm pulsed dye laser with and without intralesional corticosteroids. Dermatologic Surgery 29(1):25–29PubMed

28.

Higgins, J., et al., Cochrane Handbook for Systematic Reviews of Interventions version 6.1. 2020, Cochrane.

29.

Review Manager (RevMan) [Computer program]. 2020, The Cochrane Collaboration.

30.

Asilian A, Darougheh A, Shariat F (2012) New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for the treatment of keloid and hypertrophic scars. Journal of Isfahan Medical School 29(173):2978

31.

Behera B et al (2016) Therapeutic efficacy of intralesional steroid with carbon dioxide laser versus with cryotherapy in treatment of Keloids: a randomized controlled trial. Dermatologic Surgery 42(10):1188–1198CrossRef

32.

Meymandi SS, Moosazadeh M, Rezazadeh A (2016) Comparing two methods of cryotherapy and intense pulsed light with triamcinolone injection in the treatment of keloid and hypertrophic scars: a clinical trial. Osong Public Health and Research Perspectives 7(5):313–319CrossRef

33.

Manuskiatti, W., et al., [ABSTRACT] A split scar comparison study of hypertrophic scar treatment with fractional laser vs fractional laserassisted topical corticosteroids delivery. Lasers in Surgery and Medicine, 2017. 49(Supplement 28): p. 23.

34.

Blome-Eberwein SA et al (2018) [ABSTRACT] Does topical steroid after fractional CO2 laser treatment of scars make a clinical difference? Journal of Burn Care and Research 39(Supplement 1):S43

35.

Alsharnoubi J et al (2018) Evaluation of scars in children after treatment with low-level laser. Lasers in Medical Science 33(9):1991–1995CrossRef

Title: A systematic review of randomised controlled trials investigating laser assisted drug delivery for the treatment of keloid and hypertrophic scars
Authors: Kelvin Truong
Ines Prasidha
Tevi Wain
Publication date: 01-02-2022
Publisher: Springer London
Keywords: CO2 Laser
Keloid
Laser
Published in: Lasers in Medical Science / Issue 1/2022
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-021-03296-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A systematic review of randomised controlled trials investigating laser assisted drug delivery for the treatment of keloid and hypertrophic scars

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2022

Low-intensity photobiomodulation at 632.8 nm increases tgfβ3, col2a1, and sox9 gene expression in rat bone marrow mesenchymal stem cells in vitro

The effectiveness of high-intensity laser therapy on pain, range of motion, functional capacity, quality of life, and muscle strength in subacromial impingement syndrome: a 3-month follow-up, double-blinded, randomized, placebo-controlled trial

Efficacy and safety of non-thermal nitrogen plasma versus long-pulsed Nd:YAG laser for hand rejuvenation

Monitoring of the choline/lipid ratio by 1H-MRS can be helpful for prediction and early detection of tumor response to nano-photo-thermal therapy

The effect of Q-switched 1064-nm dymium-doped yttrium aluminum garnet laser on the skin barrier and collagen synthesis through miR-24-3p

Efficacy and safety of intense pulsed light using a dual-band filter for the treatment of facial acne vulgaris